z-logo
Premium
Lactam Formation Increases Receptor Binding, Adenylyl Cyclase Stimulation and Bone Growth Stimulation by Human Parathyroid Hormone (hPTH)(1–28)NH 2
Author(s) -
Whitfield J. F.,
Morley P.,
Willick G. E.,
Isaacs R. J.,
MacLean S.,
Ross V.,
Barbier J.R.,
Divieti P.,
Bringhurst F. R.
Publication year - 2000
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1359/jbmr.2000.15.5.964
Subject(s) - adenylyl cyclase , parathyroid hormone , endocrinology , medicine , forskolin , stimulation , receptor , chemistry , parathyroid hormone receptor , agonist , biology , calcium , hormone receptor , cancer , breast cancer
Human parathyroid hormone (1–28)NH 2 [hPTH(1–28)NH 2 ] is the smallest of the PTH fragments that can fully stimulate adenylyl cyclase in ROS 17/2 rat osteoblast‐like osteosarcoma cells. This fragment has an IC 50 of 110 nM for displacing 125 I‐[Nle 8,18 , Tyr 34 ]bovine PTH(1–34)NH 2 from HKRK B7 porcine kidney cells, which stably express 950,000 human type 1 PTH/PTH‐related protein (PTHrP) receptors (PTH1Rs) per cell. It also has an EC 50 of 23.9 nM for stimulating adenylyl cyclase in ROS 17/2 cells. Increasing the amphiphilicity of the α‐helix in the residue 17–28 region by replacing Lys27 with Leu and stabilizing the helix by forming a lactam between Glu 22 and Lys 26 to produce the [Leu 27 ]cyclo(Glu 22 ‐Lys 26 )hPTH(1–28)NH 2 analog dramatically reduced the IC 50 for displacing 125 I‐[Nle 8,18 , Tyr 34 ]bPTH(1–34)NH 2 from hPTHIRs from 110 to 6 nM and dropped the EC 50 for adenylyl cyclase stimulation in ROS 17/2 cells from 23.9 to 9.6 nM. These modifications also increased the osteogenic potency of hPTH(1–28)NH 2 . Thus, hPTH(1–28)NH 2 did not significantly stimulate either femoral or vertebral trabecular bone growth in rats when injected daily at a dose of 5 nmol/100 g body weight for 6 weeks, beginning 2 weeks after ovariectomy (OVX), but it strongly stimulated the growth of trabeculae in the cancellous bone of the distal femurs and L5 vertebrae when injected at 25 nmol/100 g body weight. By contrast [Leu 27 ]cyclo(Glu 22 ‐Lys 26 )hPTH(1–28)NH 2 significantly stimulated trabecular bone growth when injected at 5 nmol/100 g of body weight. Thus, these modifications have brought the bone anabolic potency of hPTH(1–28)NH 2 considerably closer to the potencies of the larger PTH peptides and analogs. (J Bone Miner Res 2000;15:964–970)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom